Table 3.
Correct responses regarding selected aspects of the diagnosis and management of neonatal cholestasis
| Title of pediatric providers’ | Biliary atresia should be ruled out first in NC, n (%) | Liver biopsy is most definitive investigation of NC, n (%) | Ursodeoxycholic acid is a supportive therapy of cholestasis, n (%) | Refer to pediatric gastroenterologist if the child has prolonged cholestasis, n (%) |
|---|---|---|---|---|
| Pediatric intern | 3 (3.3) | 5 (5.4) | 11 (5.4) | 15 (10.9) |
| Pediatric resident | 19 (20.7) | 24 (26.1) | 67 (32.8) | 38 (27.5) |
| Pediatric specialist | 11 (12.0) | 16 (17.4) | 30 (14.7) | 18 (13.0) |
| Pediatric consultant | 50 (54.3) | 28 (30.4) | 51 (25.0) | 47 (34.1) |
| Family physicians | 9 (9.8) | 19 (20.7) | 45 (22.1) | 20 (14.5) |
| Total | 92 (18.9) | 92 (18.9) | 204 (41.8) | 138 (28.3) |
| P | <0.001 | <0.001 | 0.061 | <0.001 |
NC – Neonatal cholestasis